Graham Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,650
Closed -$245K 1461
2024
Q4
$245K Buy
+11,650
New +$270K ﹤0.01% 1016
2023
Q1
Sell
-24,942
Closed -$334K 1261
2022
Q4
$334K Sell
24,942
-40,638
-62% -$545K 0.01% 861
2022
Q3
$871K Buy
+65,580
New +$1.13M 0.03% 541

Other funds holding PAHC

Graham Capital Management's PAHC Position: Q1 2025 in Review

Graham Capital Management sold out of Phibro Animal Health (PAHC) in Q1 2025, closing a stake of 11,650 shares — an estimated $245K sold.

Graham Capital Management first reported a position in PAHC in Q3 2022 and held it in 3 quarters. The position peaked at $871K in Q3 2022. 182 funds tracked by Wall St. Rank hold PAHC as of Q1 2025.

  • Graham Capital Management reported no remaining Phibro Animal Health position as of Q1 2025 after selling out during the quarter.
  • Graham Capital Management sold 11,650 Phibro Animal Health shares in Q1 2025, an estimated $245K.
  • Graham Capital Management first reported a position in Phibro Animal Health in Q3 2022 and held it in 3 quarters.
  • Graham Capital Management's Phibro Animal Health position peaked at $871K in Q3 2022.
  • 182 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2025.

Based on Graham Capital Management's 13F filing for Q1 2025, filed 15 May 2025.